Q32 Bio
QTTB
102 hedge funds and large institutions have $574M invested in Q32 Bio in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 14 reducing their positions, and 13 closing their positions.
271% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 14
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
12% more funds holding
Funds holding: 91 → 102 (+11)
0.04% more ownership
Funds ownership: 4.6% → 4.64% (+0.04%)
1% less capital invested
Capital invested by funds: $582M → $574M (-$7.95M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
82% less call options, than puts
Call options by funds: $250K | Put options by funds: $1.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.4M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$9.76M |
| 3 |
State Street
Boston,
Massachusetts
|
+$9.5M |
| 4 |
JP Morgan Chase
New York
|
+$6.91M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$62.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$8.54M |
| 3 |
CAC
Cowen and Company
New York
|
-$5.11M |
| 4 |
GTP
Global Thematic Partners
New York
|
-$3.4M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$1.97M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Rockefeller Capital Management
New York
| $1K | +$800 | +3 | New |
|
|
DM
102
Deerfield Management
New York
| – | -$62.7M | -224,295 | Closed |
|
|
GTP
103
Global Thematic Partners
New York
| – | -$3.4M | -12,138 | Closed |
|
104
Balyasny Asset Management
Chicago,
Illinois
| – | -$752K | -2,689 | Closed |
|
105
Invesco
Atlanta,
Georgia
| – | -$542K | -1,937 | Closed |
|
106
Two Sigma Investments
New York
| – | -$258K | -923 | Closed |
|
|
AC
107
Amia Capital
London,
United Kingdom
| – | -$218K | -781 | Closed |
|
|
CCM
108
Courage Capital Management
Nashville,
Tennessee
| – | -$155K | -556 | Closed |
|
109
UBS Group
Zurich,
Switzerland
| – | -$137K | -491 | Closed |
|
110
Group One Trading
Chicago,
Illinois
| – | -$75.2K | -282 | Closed |
|
111
Marshall Wace
London,
United Kingdom
| – | -$68K | -242 | Closed |
|
|
PA
112
Parallel Advisors
San Francisco,
California
| – | -$8K | -31 | Closed |
|
|
CG
113
Cutler Group
San Francisco,
California
| – | -$7.46K | -28 | Closed |
|
|
MAM
114
Meeder Asset Management
Dublin,
Ohio
| – | -$3K | -11 | Closed |
|
QTTB Hedge Fund Activity: Q2 2020 in Review
102 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2020, worth a combined $574M — down 1.4% from $582M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new QTTB positions and 13 closed out — a net gain of 11 holders — while 52 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock, adding an estimated $10.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $62.7M sold.
- 102 institutional investors held Q32 Bio (QTTB) as of Q2 2020, up from 91 in Q1 2020.
- Funds reported $574M of Q32 Bio stock for Q2 2020, down 1.4% quarter-over-quarter.
- 24 funds opened new Q32 Bio positions in Q2 2020 and 13 closed out, a net change of +11 holders.
- The largest Q32 Bio buyer in Q2 2020 was BlackRock, an estimated $10.4M added.
- The largest Q32 Bio seller in Q2 2020 was Deerfield Management, an estimated $62.7M sold.
Based on aggregated 13F filings for Q2 2020.